Literature DB >> 11423722

Insights into the role of the von Hippel-Lindau gene product. A key player in hypoxic regulation.

P H Maxwell1, C W Pugh, P J Ratcliffe.   

Abstract

Many adaptive responses to hypoxia involve changes in gene transcription mediated by the hypoxia-inducible factor 1 complex. Central to this is oxygen-dependent proteolysis of the alpha subunit, which has recently been shown to require the von Hippel-Lindau tumour-suppressor protein. This observation provides one mechanism by which inherited defects in the von Hippel-Lindau gene could cause features of the clinical syndrome, and offers insight into the events leading to sporadic clear cell renal cancer. Furthermore, it clearly implicates the von Hippel-Lindau tumour-suppressor protein in the biochemistry of oxygen sensing. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423722     DOI: 10.1159/000052617

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  4 in total

1.  The requirement of c-Jun N-terminal kinase 2 in regulation of hypoxia-inducing factor-1α mRNA stability.

Authors:  Dongyun Zhang; Jingxia Li; Min Zhang; Guangxun Gao; Zhenghong Zuo; Yonghui Yu; Linda Zhu; Jimin Gao; Chuanshu Huang
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

Review 2.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

3.  JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70.

Authors:  Dongyun Zhang; Jingxia Li; Max Costa; Jimin Gao; Chuanshu Huang
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

4.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.